Clinical Trial

To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2024 (before its estimated November 23, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study was conducted to evaluate recombinant human follicle stimulating hormone-CTP fusion protein injection or placebo combined with chorionic gonadotropin for injection
Trial Details
NCT Number NCT06561594
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Idiopathic Hypogonadotropic Hypogonadism
Enrollment 60 participants
Start Date 2024-09-20
Primary Completion 2024-11-23 (estimated)
Study Completion 2026-12-23 (estimated)
Updated on ClinicalTrials.gov 2024-08-20